From: Efficacy and tolerability of sofosbuvir and daclatasvir for treatment of hepatitis C genotype 1 & 3 in patients undergoing hemodialysis- a prospective interventional clinical trial
Gender
Cirrhosis
Previous Treatment
Baseline PCR (log 10 IU/ml)
ETR
SVR12
PCR (log 10 IU/ml)
Genotype
Male
No
Yes
5.86
Not Detected
5.51
1
Female
5.60
4.11
5.50